ADMA BIOLOGICS, INC. 10-Q filing
Filed 2025-08-06 · Report date 2025-06-30 · 2025
Filing metadata
- Accession number
- 0001140361-25-029177
- Form type
- 10-Q
- CIK
- 0001368514
- Primary document
- https://www.sec.gov/Archives/edgar/data/1368514/000114036125029177/ef20049201_10q.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for ADMA BIOLOGICS, INC..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $236.8M | - | - |
| Cost Of Revenue | $108.5M | - | - |
| Gross Profit | $128.3M | - | - |
| Operating Income | $77.7M | - | - |
| Net Income | $61.1M | - | - |
| Eps Basic | 0.26 | - | - |
| Eps Diluted | 0.25 | - | - |
| Cash And Equivalents | $90.3M | - | - |
| Total Assets | $558.4M | - | - |
| Total Liabilities | $160.1M | - | - |
| Shareholders Equity | $398.3M | - | - |
| Operating Cash Flow | $1.5M | - | - |
| Capital Expenditures | $7.1M | - | - |